首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Study of the Role of siRNA Mediated Promoter Methylation in DNMT3B Knockdown and Alteration of Promoter Methylation of CDH1 GSTP1 Genes in MDA-MB -453 Cell Line
【2h】

Study of the Role of siRNA Mediated Promoter Methylation in DNMT3B Knockdown and Alteration of Promoter Methylation of CDH1 GSTP1 Genes in MDA-MB -453 Cell Line

机译:siRNA介导的启动子甲基化在DNMT3B敲除和MDA-MB -453细胞系中CDH1GSTP1基因启动子甲基化改变中的作用研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Promoter methylation is one of the main epigenetic mechanisms that leads to the inactivation of tumor suppressor genes during carcinogenesis. Due to the reversible nature of DNA methylation, many studies have been performed to correct theses epigenetic defects by inhibiting DNA methyltransferases (DNMTs). In this case novel therapeutics especially siRNA oligonucleotides have been used to specifically knock down the DNMTs at mRNA level. Also many studies have focused on transcriptional gene silencing in mammalian cells via siRNA mediated promoter methylation. The present study was designed to assess the role of siRNA mediated promoter methylation in DNMT3B knockdown and alteration of promoter methylation of Cadherin-1 (CDH1), Glutathione S-Transferase Pi 1(GSTP1), and DNMT3B genes in MDA-MB-453 cell line.MDA-MB-453 cells were transfected with siDNMT targeting DNMT3B promoter and harvested at 24 and 48 h post transfection to monitor gene silencing and promoter methylation respectively. DNMT3B expression was monitored by quantitative RT-PCR method. Promoter methylation was quantitatively evaluated using differential high resolution melting analysis. A non-significant 20% reduction in DNMT3B mRNA level was shown only after first transfection with siDNMT, which was not reproducible. Promoter methylation levels of DNMT3B, CDH1, and GSTP1 were detected at about 15%, 70% and 10% respectively, in the MDA-MB-453 cell line, with no significant change after transfection.Our results indicated that siDNMT sequence were not able to affect promoter methylation and silencing of DNMT3B in MDA-MB-453 cells. However, quantitation of methylation confirmed a hypermethylated phenotype at CDH1 and GSTP1 promoters as well as a differential methylation pattern at DNMT3B promoter in breast cancer.
机译:启动子甲基化是致癌过程中导致肿瘤抑制基因失活的主要表观遗传机制之一。由于DNA甲基化的可逆性,已经进行了许多研究,通过抑制DNA甲基转移酶(DNMT)来纠正这些表观遗传缺陷。在这种情况下,新的疗法,尤其是siRNA寡核苷酸,已被用于在mRNA水平特异性敲低DNMT。同样,许多研究集中于通过siRNA介导的启动子甲基化在哺乳动物细胞中实现转录基因沉默。本研究旨在评估siRNA介导的启动子甲基化在DNMT3B敲低中的作用以及MDA-MB-453细胞中Cadherin-1(CDH1),谷胱甘肽S-转移酶Pi 1(GSTP1)和DNMT3B基因的启动子甲基化改变的作用。用靶向DNMT3B启动子的siDNMT转染MDA-MB-453细胞,并在转染后24和48小时收获,以分别监测基因沉默和启动子甲基化。通过定量RT-PCR方法监测DNMT3B表达。使用差异高分辨率解链分析定量评估了启动子甲基化。仅在第一次转染siDNMT后,才显示DNMT3B mRNA水平降低了20%,但没有显着降低,这是不可复制的。在MDA-MB-453细胞系中检测到的DNMT3B,CDH1和GSTP1的启动子甲基化水平分别约为15%,70%和10%,转染后无明显变化。我们的结果表明siDNMT序列无法影响MDA-MB-453细胞中启动子甲基化和DNMT3B沉默。但是,甲基化的定量证实了乳腺癌中CDH1和GSTP1启动子的甲基化表型以及DNMT3B启动子的甲基化模式差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号